Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martinez

Showing results (421-430 of 600) with videos related to

Pageof 60
Sort By:
Nature Communications|August 12, 2016
Identification of Siglec-1 null individuals infected with HIV-1Javier Martinez-Picado, Paul J McLaren, Itziar Erkizia, et al.
Plos One|December 3, 2014
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individualsMarta Massanella, Dan Ouchi, Silvia Marfil, et al.
Journal of the American Nutrition Association|October 9, 2024
Effect of a Multifactorial Weight Loss Intervention on HDL Cholesterol Efflux Capacity and Immunosenescence: A Randomized Controlled TrialLaura Díez-Ricote, Esther Cuadrado-Soto, Andrés Pastor-Fernández, et al.
Blood|October 24, 2008
Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathwayNuria Izquierdo-Useros, Mar Naranjo-Gómez, Jacob Archer, et al.
Journal of Virology|April 29, 2016
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral ReactivationNicolas Noel, Ruth Peña, Annie David, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2020
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruptionViviane M Andrade, Carla Mavian, Dunja Babic, et al.
Ebiomedicine|June 25, 2020
Extremely low viral reservoir in treated chronically HIV-1-infected individualsCristina Gálvez, Victor Urrea, Judith Dalmau, et al.
Medicine|July 8, 2022
Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatmentNomonde Bengu, Noxolo Mchunu, Sijabulile Mokhethi, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2018
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIsMaria C Puertas, Elisabet Gómez-Mora, José R Santos, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 13, 2023
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infectionIsaac Rosado-Sánchez, Inés Herrero-Fernández, Salvador Sobrino, et al.
Pageof 60

Showing results (421-430 of 600) with videos related to

Sort By:
Pageof 60
Nature Communications|August 12, 2016
Identification of Siglec-1 null individuals infected with HIV-1Javier Martinez-Picado, Paul J McLaren, Itziar Erkizia, et al.
Plos One|December 3, 2014
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individualsMarta Massanella, Dan Ouchi, Silvia Marfil, et al.
Journal of the American Nutrition Association|October 9, 2024
Effect of a Multifactorial Weight Loss Intervention on HDL Cholesterol Efflux Capacity and Immunosenescence: A Randomized Controlled TrialLaura Díez-Ricote, Esther Cuadrado-Soto, Andrés Pastor-Fernández, et al.
Blood|October 24, 2008
Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathwayNuria Izquierdo-Useros, Mar Naranjo-Gómez, Jacob Archer, et al.
Journal of Virology|April 29, 2016
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral ReactivationNicolas Noel, Ruth Peña, Annie David, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2020
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruptionViviane M Andrade, Carla Mavian, Dunja Babic, et al.
Ebiomedicine|June 25, 2020
Extremely low viral reservoir in treated chronically HIV-1-infected individualsCristina Gálvez, Victor Urrea, Judith Dalmau, et al.
Medicine|July 8, 2022
Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatmentNomonde Bengu, Noxolo Mchunu, Sijabulile Mokhethi, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2018
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIsMaria C Puertas, Elisabet Gómez-Mora, José R Santos, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 13, 2023
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infectionIsaac Rosado-Sánchez, Inés Herrero-Fernández, Salvador Sobrino, et al.
Pageof 60